Improving asthma management: The case for mandatory inclusion of dose counters on all rescue bronchodilators

Journal of Asthma

Volumn 50, Issue 6, 2013, Pages 658-663

  Conner, Jill B ^a   Buck, Philip O ^a  

^a TEVA PHARMACEUTICALS   (Israel)

Author keywords

Asthma; Beta agonists; Dose counter; MDI; Metered dose inhaler

Indexed keywords

BRONCHODILATING AGENT;

ARTICLE; ASTHMA; BRONCHOSPASM; HUMAN; METERED DOSE INHALER; MORBIDITY;

ASTHMA; BRONCHODILATOR AGENTS; EQUIPMENT DESIGN; HUMANS; METERED DOSE INHALERS;

EID: 84880520454     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2013.789056     Document Type: Article

References (29)

1. KimH, Mazza J. Asthma. Allergy Asthma Clin Immunol 2011; 7(Suppl 1):S2
2. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung, and Blood Institute. NIH Publication 07-4051. 2007. Available at: http://www.ncbi. nlm. nih.gov/books/NBK7232/. Accessed June 14, 2012
3. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FizGerald M, Gibson P, Ohta K, O'Byrne P, Pdersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143-178
4. American Lung Association. Trends in asthma morbidity and mortality. July, 2011. Available at: http://www.lung.org/finding-cures/ourresearch/trend- reports/asthma-trend-report.pdf. Accessed June 14, 2012
5. Asthma in the US. Growing every year. Available at: http://www.cdc.gov/ VitalSigns/Asthma/. Accessed February 6, 2012
6. United States Environmental Protection Agency. Asthma facts. 2011; EPA-402-F-04-019. Available at: http://www.epa.gov/asthma/pdfs/asth ma-fact-sheet-en.pdf. Accessed June 14, 2012
7. Asthma statistics. Available at: http://www.aaaai.org/about-the-aaaai/ newsroom/asthma-statistics.aspx. Accessed February 6, 2012
8. Sullivan PW, Ghushchyan VH, Slejko JF, Belozeroff V, Globe DR, Lin S-L. The burden of adult asthma in the United States: Evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol 2011; 127:363-369
9. Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH, Sullivan SD. Asthma control, severity, and quality of life: Quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 2007; 120:396-402
10. Lee-Wong M, Chou V, Ogawa Y. Formoterol fumarate inhalation powder vs albuterol nebulizer for the treatment of asthma in the acute care setting. Ann Allergy Asthma Immunol 2008; 100:146-152
11. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006 April 19; (2): CD000052. doi: 10. 1002/14651858. CD000052. pub2
12. Rubin BK. What does it mean when a patient says, "My asthma medication is not working?". Chest 2004; 126:972-981
13. Schultz RK. Drug delivery characteristics of metered-dose inhalers. J Allergy Clin Immunol 1995; 96:284-287
14. Sander N, Fusco-Walkert SJ, Harder JM, Chipps BE. Dose counting and the use of pressurized metered-dose inhalers: Running on empty. Ann Allergy Asthma Immunol 2006; 97:34-38
15. Ogren RA, Baldwin JL, Simon RA. How patients determine when to replace their metered-dose inhalers. Ann Allergy Asthma Immunol 1995; 75:485-489
16. Guidance for Industry: Integration of dose-counting mechanisms into MDI drug products. Available at: http://www.fda.gov/cder/guidance/index. htm. Accessed June 14, 2012
17. Rubin BK, Durotoye L. How do patients determine that their metereddose inhaler is empty?. Chest 2004; 126:1134-1137
18. Hess DR. Aerosol delivery devices in the treatment of asthma. Respir Care 2008; 53:699-723
19. Guidance for Industry. Metered dose inhaler (MDI) and dry powder inhaler (DPI) drug products. Chemistry, manufacturing and controls. Available at: http://www.fda.gov/downloads/Drugs/Guidances/ucm070573.pdf. Accessed March 12, 2013
20. Rickenbach MA, Julious SA. Assessing fullness of asthma patients' aerosol inhalers. Br J Gen Pract 1994; 44:317-318
21. Holt S, Holt A, Weatherall M, Masoli M, Beasley R. Metered dose inhalers: A need for dose counters. Respirology 2005; 10:105-106
22. Wasserman RL, Sheth K, Lincourt WR, Locantore NW, Carranza-Rosenzweig J, Crim C. Real-world assessment of a metered-dose inhaler with integrated dose counter. Allergy Asthma Proc 2006; 27:486-492
23. Sheth K, Wasserman RL, Lincourt WR, Locantore NW, Carranza-Rosenzweig J, Crim C. Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction. Int J Clin Pract 2006; 60: 1218-1224
24. LaForce C, Weinstein C, Nathan RA, Weinstein SF, Staudinger H, Meltzer EO. Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination. J Asthma 2011; 48:625-631
25. Pereira ED, Cavalcante AG, Pereira EN, Lucas P, Holanda MA. Asthma control and quality of life in patients with moderate or severe asthma. J Bras Pneumol 2011; 37:705-711
26. ProAir® HFA (albuterol sulfate) Inhalation Aerosol prescribing information. Teva Respiratory, LLC, Horsham, PA. Rev 03/2012
27. Ventolin® HFA (albuterol sulfate) prescribing information. GlaxoSmithKline, Research Triangle Park, NC. Rev 10/2012
28. National Heart, Lung, and Blood Institute. Chartbook on Cardiovascular, Lung and Blood Diseases. Available at: http://www.nhlbi. nih.gov/resources/docs/ 2009-ChartBook.pdf. Accessed February 1, 2012
29. Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol 2011; 127:145-152